Rocket Pharmaceuticals In...

NASDAQ: RCKT · Real-Time Price · USD
3.08
0.03 (0.98%)
At close: Aug 18, 2025, 10:39 AM

Rocket Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
163.63M 55.9M 140.52M 232.69M
Short-Term Investments
208.7M 317.27M 215.88M 156.05M
Long-Term Investments
1.36M 34.32M 43.28M 1.34M
Other Long-Term Assets
529K 1.91M 1.95M 1.8M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
5.85M 5.05M 7.67M n/a
Total Current Assets
378.18M 378.22M 364.06M 392.06M
Property-Plant & Equipment
83.32M 87.59M 77.64M 72.35M
Goodwill & Intangibles
64.3M 64.3M 64.88M 30.82M
Total Long-Term Assets
149.52M 188.12M 187.75M 104.96M
Total Assets
527.7M 566.34M 551.81M 497.02M
Account Payables
1.63M n/a n/a n/a
Deferred Revenue
n/a n/a -36.66M -482
Short-Term Debt
n/a 2.72M 2.51M 2.55M
Other Current Liabilities
36.2M 7.21M 39.67M 11.93M
Total Current Liabilities
40.68M 48.51M 39.17M 22.17M
Long-Term Debt
n/a 22.33M 20.36M 20.05M
Other Long-Term Liabilities
1.14M 2.94M 2.6M 80K
Total Long-Term Liabilities
23.78M 25.26M 22.95M 20.13M
Total Liabilities
64.47M 73.77M 62.12M 42.3M
Total Debt
25.5M 25.04M 22.87M 22.6M
Common Stock
1.06M 903K 791K 645K
Retained Earnings
-1.22B -959.37M -713.77M -491.91M
Comprehensive Income
66K 319K -357K -161K
Shareholders Equity
463.23M 492.57M 489.69M 454.72M
Total Investments
208.7M 351.59M 259.15M 156.05M